UTMB Galveston
Galveston, Texas, 77555, United States
NCT Number: NCT03510260
· The target population for our study is women who present in their last clinic visit before delivery and are scheduled for an elective cesarean section. In that visit, the provider will notify the research team in order for the subject to be screened for the study. If the subject consents to participation, written informed consent will be obtained by person-to-person contact. The PI, study coordinator, or a collaborator will be responsible for the informed consent. After in-formed consent is obtained, the patient will be randomized to the following study groups:
The control group will undergo regular consenting only.
Study group I (e-confirmed consent only) will receive an electronic invitation to complete the consent process electronically and will proceed through the Confirmed Consent system prior to arrival to labor and delivery on day of surgery, which is the routine patient flow at this time. After completion of the survey, the subject will sign the regular paper consent for the procedure as standard in our institution.
The study group II will undergo the same intervention as group II but the COMRADE survey questionnaire will be obtained by phone or in person after the completion of the paper consent form.
Looking for future studies?
Notify Me18 year–50 year
Female
Interventional
Not applicable
Galveston, Texas, 77555, United States
4.1 Screening, Recruitment, and Consenting:
The data collected will not be used for clinical diagnosis or treatment purposes.
Subjects will be reassured that participation in the study is voluntary and will not interfere with diag-nose or treatment of her condition.
The subjects will receive the same care and expertise as any other patient treated in our institution.
4.2. Randomization and Masking A confidential computer-generated simple randomization scheme (using STATA 14, Dallas, TX) will be prepared and provided on an ongoing basis to our study coordinator. A randomization log with group assignment, subject name, and medical record number will be used to track the randomization process.
The subject will be included in the analysis by intent-to-treat once the randomization assignment has been made.
4.3. Interventions The control group will undergo regular consenting only. At our unit consent for an elective ce-sarean delivery occurs in the same day of surgery, few hours before the procedure in a private room in labor and delivery while awaiting surgery. The COMRADE questionnaire (our primary outcome) will be obtained after the completion of the paper consent form.
Study group I (e-confirmed consent only) will receive an electronic invitation to complete the consent process electronically and will proceed through the Confirmed Consent system prior to arrival to labor and delivery on day of surgery, which is the routine patient flow at this time. The COMRADE questionnaire (our primary outcome) will be obtained prior to the initiation of the traditional consent (as in control group) before the completion of the paper consent form, in order to assess satisfaction and understanding of the e-confirmed consenting process completed before the procedure. After completion of the survey, the subject will sign the regular paper consent for the procedure as standard in our institution.
The study group II will undergo the same intervention as group II but the COMRADE survey questionnaire will be obtained after the paper consent is obtained in order to assess whether both methods combined together improve the subjects' satisfaction of the consenting methods and better understanding of the surgical procedure.
4.4. Survey Collection This is our primary outcome. Before the subject has the procedure, our research staff will be collecting a survey assessing understanding of procedure and satisfaction, please see attached survey with appli-cation. This survey will be obtained according to the interventions detailed in sections 3 & 4.3
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Study group I (e-confirmed consent only) will receive an electronic invitation to complete the consent process electronically.The COMRADE questionnaire (our primary outcome) will be obtained prior to the initiation of the traditional consent (as in control group).
Other names: e-confirmed consent
The study group II will undergo the same intervention as group II but the COMRADE survey questionnaire will be obtained after the paper consent
Other names: e-confirmed consent plus paper consent
Subject will go through the consenting process at the day of surgery at the preop visit as standard in our institution only.
Other names: Standard paper consent only
Time frame: Up to 7 days after delivery
a survey assessing understanding of procedure and satisfaction,
Time frame: Up to 7 days after delivery
Survey or questionnaire to assess subject's understanding of the planned procedure
The University of Texas Medical Branch, Galveston
Other
Electronic Confirmed Versus Conventional Consenting Process (ECCCO)
Acronym: ECCCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07736118
Agnosia, Behavior
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT04497922
Behavior, COVID-19
Boston, Massachusetts, United States
View Trial DetailsNCT05931432
Anxiety Disorders, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05462938
Adverse Event, Behavior
Ioannina, Epirus, Greece
View Trial Details